Med Lasers 2022; 11(1): 1-7  https://doi.org/10.25289/ML.2022.11.1.1
Review of Scar Assessment Scales
Jae Wan Park1,*, Young Gue Koh1,*, Sun Hye Shin1, Young-Jun Choi2, Won-Serk Kim2, Hyun Ho Yoo3, Jung Ok Lee4, You Na Jang4, Jaeyoung Kim5, Kapsok Li1, Beom Joon Kim1, Kwang Ho Yoo6,
1Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea
2Department of Dermatology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
3Department of Orthopedic Surgery, Nanoori Hospital, Seoul, Korea
4Department of Medicine, Graduate School, Chung-Ang University, Seoul, Korea
5CK Exogene, Inc., Seongnam, Korea
6Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea
Correspondence to: Kwang Ho Yoo
E-mail: psyfan9077@naver.com
ORCID: https://orcid.org/0000-0002-0137-6849

*These two authors contributed equally to this work as the first authors.
Received: February 8, 2022; Accepted: March 14, 2022; Published online: March 30, 2022.
© Korean Society for Laser Medicine and Surgery. All rights reserved.

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Scars that occur during wound healing can cause several cosmetic and functional problems and can exhibit various clinical features. From a therapeutic point of view, if scarring is severe, surgical removal is considered. However, if it is not severe, non-invasive methods, such as laser treatment, are given priority. It is important to select the ideal scar assessment method for the appropriate treatment of skin scars. To aid in this endeavor, we reviewed the following methods of scar assessment: The Vancouver Scar Scale (VSS), Modified Vancouver Scar Scale (mVSS), Seattle Scale, Mapping Assessment of Scars and Photographs (MAPS), Hamilton Scale, Manchester Scale, Patient and Observer Scar Assessment Scale (POSAS), Stony Brook Scar Evaluation Scale (SBSES), University of North Carolina “4P” Scar Scale (UNC4P), Visual Analog Scale (VAS), and the Dermatology Life Quality Index (DLQI). The objective of this study was to summarize and evaluate the various scar assessment methods that are commonly used in clinical practice.
Keywords: Assessment; Scale; Scar; Review
INTRODUCTION

Scars appear due to imbalances between the anabolic and catabolic phases of the process of filling defects in the epidermis and dermis. They are also seen in deep-seated regions, caused by skin damage and replacement with abnormal connective tissue. Scars can be caused by trauma, including burns and injuries, inflammatory skin disorders, and surgery.1 Scars are one of the most common illnesses that affect a patient cosmetically. This can not only affect the quality of life of patients, but also cause financial and mental health problems. Surgical and nonsurgical treatments are available for scar management. Various laser treatments have recently gained traction as non-surgical alternatives. Various treatments, such as cryotherapy and bleomycin injection therapy, are used in combination to treat these lesions.2,3

In general, scars have a shape similar to that of the surrounding tissue because of a secondary process in which the wound site shrinks due to the condensation of surrounding cells over time. This allows scars to be classified into immature and mature scars. However, scars are generally classified into depressed, atrophic, or elevated scars depending on their morphology (classification by contour). Although this classification is important for determining the correct treatment for scars, it is equally important to choose an appropriate scar assessment method to evaluate the course and effectiveness of the treatment process itself. Scar assessment scales that are currently used include the Vancouver Scar Scale (VSS), Visual Analog Scale (VAS), Patient and Observer Scar Assessment Scale (POSAS), Manchester Scar Scale (MSS), and the Stony Brook Scar Evaluation Scale (SBSES). However, to date, there is no gold standard in the evaluation of scars. The most important reason for this is that most current scar assessment methods focus on the cosmetic features or problems associated with scars. There is reduced consideration of the functional problems and psychological sequelae that the patient might encounter. It can be said that a simple evaluation method is actually ideal to consider all the aspects of the scar as a whole. Hence, this review summarizes various scar assessment methods that are currently used in clinical practice.

VANCOUVER SCAR SCALE

The VSS was the first validated scar scale to be widely used in clinical scar assessment, as early as 1990. It is one of the most frequently used scales till date.4 The VSS evaluates four indicators: vascularity, pigmentation, pliability, and height. It has a score ranging from 0-13 (Table 1). The VSS set a precedent for systematic scar assessment by collecting subjective assessments and using a semiquantitative approach. However, this method has multiple limitations. According to some studies, the VSS has insufficient efficacy and reliability, especially if the scar is large or irregular. It does not include an assessment of subjective symptoms, such as pain, itching, functional sequelae, or the psychological sequelae of scars. To aid in better understanding, the measured results are shown in Fig. 1.

Table 1 . Vancouver Scar Scale (VSS)

Scar charactersiticScore
Vascularity
Normal0
Pink1
Red2
Purple3
Pigmentation
Normal0
Hypopigmentation1
Hyperpigmentation2
Pliability
Normal0
Supple1
Yielding2
Firm3
Ropes4
Contracture5
Height
Flat0
< 2 mm1
2-5 mm2
> 5 mm3
Total score13

Figure 1. Scars assessed using the Vancouver Scar Scale, POSAS. *Observer Scar Assessment Scale; **Patient Scar Assessment Scale.
MODIFIED VANCOUVER SCAR SCALE

Owing to the limitations mentioned above, some modifications to the VSS have been suggested in literature. An important change presented by Nedelec et al. is the addition of pain and itchiness as indicators (Table 2).5 Forbes-Duchart et al. have confirmed that VSS shows reduced reliability among evaluators when assessing scars in patients with various skin pigmentations. Therefore, they proposed the use of light, medium, and dark modifiers when evaluating patients with different skin tones.6 These changes are expected to offer slight advantages over the existing VSS. However, a systematic review by Tyack et al.7 did not report any improvements in validity, reliability, or sensitivity. In addition, subjective indicators other than pain and itch are not covered by either the VSS or modified VSS.

Table 2 . Modified Vancouver Scar Scale (mVSS)

Scar charactersiticScore
Vascularity
Normal0
Pink1
Red2
Purple3
Pigmentation
Normal0
Hypopigmentation1
Mixed2
Hyperpigmentation3
Pliability
Normal0
Supple1
Yielding2
Firm3
Ropes4
Contracture5
Height
Flat0
< 2 mm1
2-5 mm2
> 5 mm3
Pain
None0
Occasional1
Requiring medication2
Pruritus
None0
Occasional1
Requiring medication2
Total score16

SEATTLE SCALE

Yeong et al. have suggested 24 standardized color photographs to assess the surface, thickness, border height, and color differences between scars and normal skin to derive a more consistent score.8 The scale increases in severity from -1 to 4, with 0 indicating a normal score. The Seattle Scale did improve reliability between evaluators. However, by design, it allows negative values for certain metrics, such as hypopigmentation and atrophy. Although these negative values help to distinguish between different scar types, they lead to an "improved" overall score, which, in turn, can lead to a misinterpretation of the degree of scarring. Owing to these limitations and the lack of evaluation of subjective symptoms, the Seattle Scale is not widely used.

MAPS (MAPPING ASSESSMENT OF SCARS AND PHOTOGRAPHS)

In 2005, Masters et al. optimized the scar assessment scale described by Young et al. by adding a localization technique consisting of matching assessments of scars and photographs (MAPS) to depict the overall appearance of scars rather than specific spots.9 Long-term follow-up observations of several months became possible through photographs. Reliability between evaluators showed a high concordance rate (0.55-0.81) when measuring border, height, thickness, and color of scars. However, it seemed to be relatively low (0.25-0.40) when evaluating the surface.

HAMILTON SCALE

The Hamilton scale is a scar assessment scale developed in 1998. It uses relatively little-known photographs.10 The observer evaluates several indicators, including surface irregularity, thickness, color, and vascularity, using photographs alone. The advantage of this scale is that it is highly reliable, even when used by novice observers. Despite its high reliability, the Hamilton scale can potentially distort the observer's interpretation because it relies on photographs rather than actual scars for evaluation. Moreover, similar to previously described scales, the Hamilton scale also lacks a component dealing with the assessment of subjective symptoms.

MANCHESTER SCAR SCALE

Beausang et al. introduced the MSS in 1998 to quantitatively assess scars based on clinical, photographic, and histological features.11 After evaluating independent scar characteristics including color, contour, radiation, texture, and distortion, the total score proportional to scar severity is derived in combination with a VAS. Although the MSS is suitable for assessing linear scars, it has been criticized for its lack of description of symptoms.

PATIENT AND OBSERVER SCAR ASSESSMENT SCALE

The introduction of the POSAS in 2004 marked a turning point in scar assessment using scales.12 POSAS is the first scale that considers both the patient’s and evaluator’s perspectives. In addition to assessing the physical properties of scars (e.g., vascularization, pigmentation, thickness, relief, and pliability), POSAS allows patients to score scar-related pain and pruritus using a 10 point scoring system (Table 3). Although subjective symptoms are considered, they are limited to only pain and pruritus; functional defects and possible psychological effects are not assessed. In 2005, a modified version of POSAS was introduced which added a subjective assessment of the effects of scarring on daily life activities. To aid in better understanding, the parameters measured are listed in Fig. 1.

Table 3 . The Patient and Observer Scar Assessment Scale (POSAS)

Observer Scar Assessment ScaleScore*
Vascularity1-10
Pigmentation1-10
Thickness1-10
Relief1-10
Pliability1-10
Total score Observer Scar scale5-50

Patient Scar Assessment Scale 1Score**

Is the scar painful?1-10
Is the scar itching?1-10

Patient Scar Assessment Scale 2Score***

Is the color of the scar different?1-10
Is the scar more stiff?1-10
Is the thickness of the scar different?1-10
Is the scar irregular?1-10
Total score Patient Scar Scale6-60

*1, Normal skin; 10, Worst scar imaginable; **1, No complaints; 10, Worst imaginable; ***1, Normal skin; 10, Very different; †catego­rized to hypopigmentation, mixed, or hyperpigmentation.


STONY BROOK SCAR EVALUATION SCALE

The Stony Brook Scar Evaluation Scale (SBSES) was developed by Singer et al. in 2007. It is based on five scar indicators: width, elevation or depression, color, suture or staple marks, and overall appearance.13 Each indicator is assigned a score between 0 and 5 points. These scores are totaled to obtain the final score. SBSES has demonstrated consistent reliability between evaluators, ranging from 0.73 to 0.85. However, it failed to include subjective indicators in its assessment of scars.

UNIVERSITY OF NORTH CAROLINA “4P” SCAR SCALE

The University of North Carolina "4P" Scar Scale (UNC4P) was developed to broaden the range of existing scar scales and qualitative assessments.14 The "4Ps" of UNC4P include pain, paresthesia, pruritus, and pliability. It evaluates scars using a score ranging from 0-12. UNC4P emphasizes the importance of subjective evaluations. However, the scale is not designed for independent use. In a study comparing scar characteristics before and after laser peeling by Hultman et al., UNC4P was only used as a supplement to the pre-existing VSS. Moreover, the reliability of UNC4P has not yet to be verified.

VISUAL ANALOG SCALE AND DERMATOLOGY LIFE QUALITY INDEX

Although the VAS and the Dermatology Life Quality Index (DLQI) are not designed for scar assessment, they have been widely used to assess scar severity and other skin disorders. The high prevalence of subjective symptoms, such as pruritus and pain, and the significant impact of scarring on the patient’s quality of life make the use of these subjective measures in clinical evaluation important. The VAS is a scale designed to evaluate a patient’s subjective pain experience quickly and easily. The patient evaluates the intensity of pain by displaying 100 mm lines on a scale from painless to the worst imaginable pain.15 Although it is not designed for scar assessment, it is commonly used for scar assessment because patients themselves can assess and attempt to quantify their subjective experience with the scars, which are not included in other scales.

The DLQI was developed in 1994 as the first dermatological assessment of quality of life.16 It evaluates factors such as pain, itch, embarrassment, social impairment, and functional impairment, through a questionnaire. The DLQI has been used in various dermatological conditions, such as psoriasis, eczema, and vitiligo, as well as scars.17

The routine use of VAS and DLQI in clinical practice, when compared with the use of other scales of scar assessment, indicates the importance of subjective indicators in supporting the holistic evaluation of a scar. The strengths and weaknesses of the various scale ranges and the parameters used to assess scarring are summarized in Tables 4 and 5.

Table 4 . Summary of scar assessment scales (1)

Scar evaluation methodScore rangeEvaluation itemDisadvantagesAdvantageMajor indication
Vancouver Scar Scale (VSS)0 (best) – 13 (worst)Vascular distribution, thickness, flexibility, pigmentationIt does not include the degree of subjective awareness of the patient.
It is difficult to apply pigmentation indicators to large, non-uniform scars.
Do not assess evaluator-dependent errors, pain, or swells.
Often used in the study of burn treatment resultsBurn scar
Modified VSS (Nedelec et al.5)0 (best) ® 16 (worst)VSS evaluation item + background, painSubjective symptoms other than itching and pain are not included.Including patient subjective symptomsBurn scar
Seattle Scale–4 ® 16 (worst)Homogeneity, thickness, boundaries, pigmentationNegative(–) measurements tend to be evaluated as rather to improve scarring.Since it is evaluated using photographic materials, it is easy to evaluate and highly responsive.
Hypopigmentation and atrophy can be measured negatively(–).
When evaluating scars with photos
Matching Assessment of Scars and Photographs (MAPS)–5 (best) – 20 (best)Seattle Scale endpoint + colorSame as Seattle ScaleImproved realibility than Seattle ScaleWhen evaluating scars with photos
Hamiltons Scale0 (best) ® 14 (worst)Homogeneity, thickness, color, blood vessel distributionLimited because it is evaluated with photographic materials.
It does not include the patient's subjective symptoms.
Since it is evaluated using photographic materials, it is easy to evaluate and highly responsive.When evaluating scars with photos
Manchester Scar Scale (MSS)5 (best) – 18 (worse)VAS endpoint + scar color, skin texture, scar texture, relationship with surrounding skin, border, size, numberEmphasis and evaluation of each item are optionalApplicable to various scars, includes physical measurements as well as clinical importance endpointsVarious scars including postoperative scar
Patient and Observer Scar Assessment Scale (POSAS)5 (worst) – 50 (best)VSS evaluation item + surface area, pain, bare skin, color, thickness, hardnessSubjective symptoms other than itching and pain are not included.
Scar assessment results may differ from patient perceptions and concerns
Focus on the severity of scars from the perspective of a doctor or patientPostoperative scar, linear scar. Useful for evaluation of scars accompanied by contracture
The Stony Brook Scar Evaluation Scale (SBSES)+0 (worst) – 5 (best)VAS evaluation item + width, thickness, color, presence or absence of suture marksIt is evaluated only as a photograph and does not include the patient's condition.
Not suitable for long-term evaluation
Indicator developed for short-term assessment of repaired burnsUseful for evaluation of suture scar
University of North Carolina "4P" Scar Scale (UNC4P)0 (best) – 12 (best)Pain, Paresthesias, Pruritus, PliabilityOriginal use restrictions (additional use for VSS) Reliability has not been evaluated.Focus on the patient's subjective symptomsUseful for evaluation of scars accompanied by subjective symptoms

Table 5 . Summary of scar assessment scales (2)

VSSModified VSS (Nedelec et al.5)Seattle scaleMAPSHamiltion scaleMSSPOSASSBSESUNC4P
Scar description
Surface areaOOO
Height/thickness/contourOOOOOOOO
Anatomic locationO
ErythemaOOO
PigmentationOOOOOOOO
Subjective symptoms/cormorbidities
PainOOO
PruritusOOO
DysesthesiaO
Functional impairmentO
Overall appearance by patientO
Overall appearance by observerOO

CONCLUSION

When assessing a scar, it is important to objectively assess the shape and size of the scar, as well as the patient's subjective symptoms (itch and pain). POSAS, a modified VSS, includes patient's subjective symptoms as well as basic scar evaluation. However, the emergence and availability of various new treatments for the management of scars mean that it’s not just cosmetic features, but also functional and psychological sequelae of scars that need to be considered. Therefore, a comprehensive evaluation method is required. However, to date, there has been no comprehensive measure of scar assessment that combines both the objective and subjective characteristics of scars. Nguyen et al. recently proposed the inclusion of functional impairment, infection, lymphedema, ulceration, skin cancer, scar type, and age.18

FUNDING
None.
CONFLICT OF INTEREST
Kwang Ho Yoo is the Editor-in-Chief of the journal but was not involved in the review process of this manuscript. Otherwise, there is no conflict of interest to declare.
AUTHOR CONTRIBUTIONS

Concept and design: KL, BJK, KHY. Analysis and interpretation: JWP, YGK, SHS. Data collection: YJC, WSK, HHY, JOL, YNJ. Writing the article: JWP, YGK. Critical revision of the article: BJK, KHY. Final approval of the article: KHY. Statistical analysis: YJC, JK. Overall responsibility: KHY.

References
  1. Limmer EE, Glass DA 2nd. A review of current keloid management: mainstay monotherapies and emerging approaches. Dermatol Ther (Heidelb) 2020;10:931-48.
    Pubmed KoreaMed CrossRef
  2. Anderson JB, Foglio A, Harrant AB, Huang CA, Hultman CS, Mathes DW, et al. Scoping review of therapeutic strategies for keloids and hypertrophic scars. Plast Reconstr Surg Glob Open 2021;9:e3469.
    Pubmed KoreaMed CrossRef
  3. Lv K, Xia Z; Chinese consensus panel on the prevention and treatment of scars. Chinese expert consensus on clinical prevention and treatment of scar. Burns Trauma 2018;6:27.
    Pubmed KoreaMed CrossRef
  4. Sullivan T, Smith J, Kermode J, McIver E, Courtemanche DJ. Rating the burn scar. J Burn Care Rehabil 1990;11:256-60.
    Pubmed CrossRef
  5. Nedelec B, Shankowsky HA, Tredget EE. Rating the resolving hypertrophic scar: comparison of the Vancouver Scar Scale and scar volume. J Burn Care Rehabil 2000;21:205-12.
    Pubmed CrossRef
  6. Forbes-Duchart L, Marshall S, Strock A, Cooper JE. Determination of inter-rater reliability in pediatric burn scar assessment using a modified version of the Vancouver Scar Scale. J Burn Care Res 2007;28:460-7.
    Pubmed CrossRef
  7. Tyack Z, Simons M, Spinks A, Wasiak J. A systematic review of the quality of burn scar rating scales for clinical and research use. Burns 2012;38:6-18.
    Pubmed CrossRef
  8. Yeong EK, Mann R, Engrav LH, Goldberg M, Cain V, Costa B, et al. Improved burn scar assessment with use of a new scar-rating scale. J Burn Care Rehabil 1997;18:353-5. discussion 352.
    Pubmed CrossRef
  9. Masters M, McMahon M, Svens B. Reliability testing of a new scar assessment tool, Matching Assessment of Scars and Photographs (MAPS). J Burn Care Rehabil 2005;26:273-84.
    Pubmed
  10. Crowe JM, Simpson K, Johnson W, Allen J. Reliability of photographic analysis in determining change in scar appearance. J Burn Care Rehabil 1998;19:183-6.
    Pubmed CrossRef
  11. Beausang E, Floyd H, Dunn KW, Orton CI, Ferguson MW. A new quantitative scale for clinical scar assessment. Plast Reconstr Surg 1998;102:1954-61.
    Pubmed CrossRef
  12. Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg 2004;113:1960-5. discussion 1966-7.
    Pubmed CrossRef
  13. Singer AJ, Arora B, Dagum A, Valentine S, Hollander JE. Development and validation of a novel scar evaluation scale. Plast Reconstr Surg 2007;120:1892-7.
    Pubmed CrossRef
  14. Hultman CS, Friedstat JS, Edkins RE, Cairns BA, Meyer AA. Laser resurfacing and remodeling of hypertrophic burn scars: the results of a large, prospective, before-after cohort study, with long-term follow-up. Ann Surg 2014;260:519-29. discussion 529-32. Erratum in: Ann Surg 2015;261:811.
    Pubmed CrossRef
  15. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976;2:175-84.
    Pubmed CrossRef
  16. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
    Pubmed CrossRef
  17. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159:997-1035. The Dermatology Life Quality Index 1994-2007: :a.
    Pubmed CrossRef
  18. Nguyen TA, Feldstein SI, Shumaker PR, Krakowski AC. A review of scar assessment scales. Semin Cutan Med Surg 2015;34:28-36.
    Pubmed CrossRef


This Article

e-submission

Archives